Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging Strategies.
CAR-T
acute myeloid leukemia
checkpoint inhibitors
immunotherapy
Journal
Bioengineering (Basel, Switzerland)
ISSN: 2306-5354
Titre abrégé: Bioengineering (Basel)
Pays: Switzerland
ID NLM: 101676056
Informations de publication
Date de publication:
20 Oct 2023
20 Oct 2023
Historique:
received:
15
09
2023
revised:
05
10
2023
accepted:
15
10
2023
medline:
28
10
2023
pubmed:
28
10
2023
entrez:
28
10
2023
Statut:
epublish
Résumé
In the last twenty years, we have witnessed a paradigm shift in the treatment and prognosis of acute myeloid leukemia (AML), thanks to the introduction of new efficient drugs or approaches to refine old therapies, such as Gemtuzumab Ozogamicin, CPX 3-5-1, hypomethylating agents, and Venetoclax, the optimization of conditioning regimens in allogeneic hematopoietic stem cell transplantation and the improvement of supportive care. However, the long-term survival of non-M3 and non-core binding factor-AML is still dismal. For this reason, the expectations for the recently developed immunotherapies, such as antibody-based therapy, checkpoint inhibitors, and chimeric antigen receptor strategies, successfully tested in other hematologic malignancies, were very high. The inherent characteristics of AML blasts hampered the development of these treatments, and the path of immunotherapy in AML has been bumpy. Herein, we provide a detailed review of potential antigenic targets, available data from pre-clinical and clinical trials, and future directions of immunotherapies in AML.
Identifiants
pubmed: 37892958
pii: bioengineering10101228
doi: 10.3390/bioengineering10101228
pmc: PMC10604866
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
HLA. 2020 Jul;96(1):3-12
pubmed: 32189430
Am J Cancer Res. 2020 Mar 01;10(3):727-742
pubmed: 32266087
Cell Stem Cell. 2010 Dec 3;7(6):708-17
pubmed: 21112565
J Immunother Cancer. 2022 Jan;10(1):
pubmed: 35017151
Leuk Res. 2007 May;31(5):599-604
pubmed: 16959316
Lancet Oncol. 2009 Mar;10(3):223-32
pubmed: 19230772
Blood. 2012 Apr 19;119(16):3734-43
pubmed: 22383801
Tumour Biol. 2013 Feb;34(1):531-42
pubmed: 23179394
Front Immunol. 2021 May 05;12:626616
pubmed: 34025638
Asian Pac J Cancer Prev. 2020 Mar 01;21(3):743-748
pubmed: 32212802
Exp Hematol. 2011 Apr;39(4):424-433.e2
pubmed: 21216276
Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2304943120
pubmed: 37549290
J Hematol Oncol. 2020 Apr 3;13(1):28
pubmed: 32245463
Clin Lymphoma Myeloma Leuk. 2021 Sep;21(9):580-597
pubmed: 34176779
N Engl J Med. 2013 Jul 11;369(2):111-21
pubmed: 23841729
Blood Adv. 2023 Aug 22;7(16):4418-4430
pubmed: 37171449
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6880-8
pubmed: 25400771
Leukemia. 2022 Jul;36(7):1703-1719
pubmed: 35732831
Immunol Rev. 2009 May;229(1):114-25
pubmed: 19426218
Annu Rev Immunol. 2008;26:677-704
pubmed: 18173375
Blood Rev. 2019 Mar;34:26-33
pubmed: 30401586
Br J Haematol. 2011 Jun;153(6):796-9
pubmed: 21477159
Int J Mol Sci. 2019 Jan 08;20(1):
pubmed: 30626126
J Immunother Cancer. 2020 Sep;8(2):
pubmed: 32929051
Blood Cancer J. 2022 Jan 28;12(1):19
pubmed: 35091554
Immunol Cell Biol. 2015 Mar;93(3):290-6
pubmed: 25367186
Mediterr J Hematol Infect Dis. 2023 Jan 01;15(1):e2023013
pubmed: 36660358
Biomark Res. 2023 Jun 17;11(1):65
pubmed: 37330575
Blood Cancer J. 2014 Jun 13;4:e218
pubmed: 24927407
Immunol Rev. 2009 May;229(1):216-31
pubmed: 19426224
Br J Haematol. 2021 Apr;193(1):155-159
pubmed: 32996123
J Clin Pharm Ther. 2022 Sep;47(9):1337-1351
pubmed: 35906791
Blood Cancer J. 2015 Jul 31;5:e330
pubmed: 26230954
J Immunother Cancer. 2018 Jun 15;6(1):56
pubmed: 29907163
Leukemia. 2022 Jan;36(1):13-22
pubmed: 34302116
Leuk Lymphoma. 2013 Jul;54(7):1517-20
pubmed: 23193950
Blood. 2002 Oct 1;100(7):2292-302
pubmed: 12239137
Blood. 2009 Feb 12;113(7):1581-8
pubmed: 18974373
Transplant Cell Ther. 2023 Apr;29(4):279.e1-279.e10
pubmed: 36572384
Cancer Med. 2023 Apr;12(8):9655-9661
pubmed: 37031462
Cancer. 2020 Jul 15;126(14):3192-3201
pubmed: 32401342
Front Oncol. 2020 May 27;10:685
pubmed: 32528876
Blood. 2021 Feb 11;137(6):751-762
pubmed: 32929488
Leuk Res. 2014 Jun;38(6):714-21
pubmed: 24746294
Leukemia. 2022 Nov;36(11):2596-2604
pubmed: 36151140
Cancer Biomark. 2018;22(3):587-595
pubmed: 29843224
Asia Pac J Clin Oncol. 2020 Apr;16(2):e12-e18
pubmed: 31612643
Bone Marrow Transplant. 1987 Oct;2(3):233-42
pubmed: 3332173
Int J Oncol. 2006 Apr;28(4):855-61
pubmed: 16525634
Exp Hematol Oncol. 2022 Mar 2;11(1):11
pubmed: 35236415
Front Oncol. 2019 Jul 23;9:655
pubmed: 31396481
Int J Mol Sci. 2020 Jul 30;21(15):
pubmed: 32751706
Cancer. 2019 May 1;125(9):1470-1481
pubmed: 30500073
Blood Adv. 2022 Apr 12;6(7):2219-2229
pubmed: 34933333
Cytotherapy. 2006;8(1):3-12
pubmed: 16627340
Sci Transl Med. 2016 Dec 7;8(368):368ra171
pubmed: 27928025
ISRN Hematol. 2012;2012:690901
pubmed: 22461998
Front Oncol. 2022 Apr 12;12:871590
pubmed: 35494081
Clin Cancer Res. 2013 Jul 15;19(14):3844-55
pubmed: 23690482
Clin Cancer Res. 2020 Apr 1;26(7):1763-1772
pubmed: 31911547
Clin Transl Med. 2022 Sep;12(9):e1043
pubmed: 36163632
J Immunother Cancer. 2021 Jul;9(7):
pubmed: 34326171
Blood. 2018 Jan 4;131(1):58-67
pubmed: 29118008
Nat Immunol. 2005 Dec;6(12):1245-52
pubmed: 16286920
J Exp Med. 2017 Feb;214(2):359-380
pubmed: 28031480
Blood Adv. 2023 Sep 26;7(18):5215-5224
pubmed: 37379271
Eur J Haematol. 2017 Sep;99(3):269-274
pubmed: 28618016
Biomark Res. 2020 Feb 13;8:6
pubmed: 32082573
Nat Rev Drug Discov. 2009 Dec;8(12):969-81
pubmed: 19855427
Cancer Immunol Immunother. 2021 Dec;70(12):3701-3708
pubmed: 34398302
Leuk Res. 2017 Jul;58:31-38
pubmed: 28407515
Mol Aspects Med. 2021 Aug;80:100870
pubmed: 32800530
Oncotarget. 2016 Sep 6;7(36):57811-57820
pubmed: 27506934
Leukemia. 2021 Nov;35(11):3282-3286
pubmed: 33833386
Hematol Oncol Stem Cell Ther. 2008 Oct-Dec;1(4):239-40
pubmed: 20058480
Biol Blood Marrow Transplant. 2016 Dec;22(12):2149-2154
pubmed: 27634018
Nat Med. 2020 Sep;26(9):1459-1467
pubmed: 32601337
Mol Ther. 2015 Jan;23(1):184-91
pubmed: 25174587
Cancers (Basel). 2022 Jun 17;14(12):
pubmed: 35740657
Blood. 2019 Jan 3;133(1):7-17
pubmed: 30361262
Front Oncol. 2022 Mar 31;12:872999
pubmed: 35433462
Int J Mol Sci. 2021 Feb 05;22(4):
pubmed: 33562512
Lancet Haematol. 2019 Sep;6(9):e480-e488
pubmed: 31400961
Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):508-513
pubmed: 33931379
J Transl Med. 2022 Dec 14;20(1):600
pubmed: 36517851
Biomed Pharmacother. 2021 May;137:111299
pubmed: 33508619
J Int Med Res. 2012;40(4):1265-74
pubmed: 22971478
Int J Mol Sci. 2019 Jun 10;20(11):
pubmed: 31185600
Transplant Cell Ther. 2022 Apr;28(4):183.e1-183.e8
pubmed: 35104660
Front Immunol. 2021 Feb 24;12:641910
pubmed: 33732262
Int J Mol Sci. 2019 Dec 27;21(1):
pubmed: 31892219
N Engl J Med. 2019 Apr 25;380(17):1628-1637
pubmed: 31018069
Cancer Immunol Res. 2019 Jan;7(1):100-112
pubmed: 30396908
Blood Cancer Discov. 2021 Sep 10;2(6):616-629
pubmed: 34778801
Lancet. 2012 Apr 21;379(9825):1508-16
pubmed: 22482940
Haematologica. 2023 Feb 01;108(2):457-471
pubmed: 35950535
Int Immunopharmacol. 2018 Sep;62:29-39
pubmed: 29990692
Ann Hematol. 2018 Sep;97(9):1717-1726
pubmed: 29705860
Blood. 2010 Jan 7;115(1):107-21
pubmed: 19887673
Biomedicines. 2023 Jun 15;11(6):
pubmed: 37371818
Transplant Cell Ther. 2021 Dec;27(12):1021.e1-1021.e5
pubmed: 34474164
J Immunother Cancer. 2022 Mar;10(3):
pubmed: 35288466
Blood. 2023 Apr 13;141(15):1884-1888
pubmed: 36332187
J Hematol Oncol. 2022 Jul 7;15(1):88
pubmed: 35799191
J Hematol Oncol. 2021 Oct 30;14(1):180
pubmed: 34717705
Oncoimmunology. 2013 Apr 1;2(4):e23849
pubmed: 23734331
Blood. 2014 May 8;123(19):3016-26
pubmed: 24652987
Cell. 2009 Jul 23;138(2):286-99
pubmed: 19632179
Exp Hematol. 2023 Sep 22;:
pubmed: 37741607
Clin Cancer Res. 2021 Jun 1;27(11):3141-3153
pubmed: 33531429
J Immunol. 2017 May 1;198(9):3746-3754
pubmed: 28330901
Nature. 2011 Jun 08;474(7350):216-9
pubmed: 21654805
Haematologica. 2023 Jul 01;108(7):1793-1802
pubmed: 36779592
Leukemia. 2011 May;25(5):792-9
pubmed: 21274000
Nat Med. 2018 Mar;24(3):282-291
pubmed: 29431743
Mycoses. 2022 Feb;65(2):233-238
pubmed: 34883533
Cells. 2023 Jun 08;12(12):
pubmed: 37371056
Blood Cancer J. 2021 Mar 17;11(3):60
pubmed: 33731681
Cell. 2009 Jul 23;138(2):271-85
pubmed: 19632178
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11103-8
pubmed: 23690610
Cancers (Basel). 2021 Aug 15;13(16):
pubmed: 34439266
Lancet Oncol. 2014 Aug;15(9):986-96
pubmed: 25008258
Nat Rev Immunol. 2018 Mar;18(3):153-167
pubmed: 28990585